Laughter Yoga is Role in Enhancing Sleep and Well-being in the Elderly
ConditionELDERLY PEOPLE
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorArtvin Coruh University
About this trial
Objective:
The study aims to evaluate the effects of Laughter Yoga on sleep quality, vitality, active aging, and quality of life in individuals aged 60 and over.
Method:
This randomized controlled experimental study will be conducted between 01.09.2024 and 31.12.2024 with elderly individuals aged 60 and over who are registered at Şavşat Family Health Center No. 1. The study population consists of 6,797 individuals. Participants will be randomly assigned to an experimental group (30) and a control group (30) using a simple randomization method. Data will be collected using a Personal Information Form, Mini-Mental State Examination, Active Aging Scale, Pittsburgh Sleep Quality Index, Subjective Vitality Scale, and Quality of Life Scale for the Elderly. The experimental group will participate in 12 Laughter Yoga sessions, conducted twice a week for 6 weeks, with each session lasting 40 minutes. No intervention will be applied to the control group. At the end of the 6th week, final measurements will be taken from both groups at the family health center.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Reside in Şavşat,
Aged 60 or over,
No issues with vision, hearing, or perception,
Scored 24 or higher on the Mini-Mental State Examination,
Disqualifiers
Scored below 24 on the Mini-Mental State Examination,
Severe hearing or perceptual impairments that hinder communication,
Major psychiatric disorders,
Underwent surgery within the last three months,
Trial design
Design model
Parallel
Treatments tested in this trial
Laughter Yoga
Other interventionLaughter Yoga Intervention: Laughter Yoga is composed of four stages: deep breathing exercises, clapping and warm-up exercises, childlike play, and laughter exercises. These stages are designed to remove barriers to laughter, enhance emotional expression through childlike play, and prepare the lungs for laughter exercises. Before the Laughter Yoga session begins, participants will be introduced to both the practice itself and to Laughter Yoga in general. The session will then proceed according to the following structure: Deep Breathing Exercises: Participants inhale through the nose for 4-5 seconds, hold their breath for 2-3 seconds, and exhale through the mouth, with lips pursed, for one second longer than the inhalation, while smiling or laughing. This exercise is performed for 10-15 minutes. Clapping and Warm-Up Exercises: Participants clap with palms and fingertips touching, keeping their hands parallel. This stimulates acupressure points in the hands. To increase group energy, a
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: Participant GroupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Pre-test
Mini Mental State Test (MMST): Assesses cognitive function on a 0-30 scale; higher scores indicate better cognitive function. The score will be reported independently.
Time frame
Initial enrollment in the studySecondary outcomes
1
Active Aging Scale
Scores range from 0 to 272 across four subscales, with higher scores indicating greater active aging. This score is reported as a separate outcome.
Time frame
From enrollment to the end of treatment at 6 weeks2
Pittsburgh Sleep Quality Index (PSQI)
Measures sleep quality, where scores of 5 or more indicate poor sleep quality. PSQI results are reported separately.
Time frame
From enrollment to the end of treatment at 6 weeks3
Subjective Vitality Scale (SVS)
Ranges from 7 to 49, with higher scores reflecting higher vitality. It is reported as an independent measure of vitality.
Time frame
From enrollment to the end of treatment at 6 weeks4
CASP-13 Quality of Life Scale
Evaluates quality of life in terms of autonomy and satisfaction, with higher scores indicating better life quality, and will be reported separately.
Time frame
From enrollment to the end of treatment at 6 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Artvin Coruh University
Lead sponsor
Ataturk University
Collaborator
Source ClinicalTrials.gov